Investors in Life Science

Hummingbird Ventures is a global early stage venture capital fund backing outlier founders. They are global seed investors, looking for outlier founders. Hummingbird believes groundbreaking companies are built by a rare breed of entrepreneur.

LRM is a venture capitalist providing smart money, giving companies the necessary oxygen for growth. Additionally, they manage three business campuses and offer opportunities for entrepreneurs seeking industrial estates. On the former mine sites be-MINE and Terhills, they are accomplishing impressive transformations.

Coinvest Capital invests in start-ups and companies undergoing business development and growth with groups of business angels.

Baltic Sandbox Ventures is a venture capital business that only invests in early-stage deep technology and life science solutions.

Novalis Biotech is an early-stage venture capital investor in life sciences. They welcome innovative concepts in healthcare and aim to support their development from the state of incorporation. Their investment focus is on “enabling technologies” in life sciences. They strongly believe in capital-light platform technology and close interaction with customers early in the life of the company. Focus areas include innovative research and manufacturing tools, bioinformatics, genomics, diagnostics, and digital health.

Sciety was started in 2016 by a founding team with diverse backgrounds in physics, business, medicine and finance. Since our start, we have invested over 1 billion SEK in 25 companies, whereof 8 companies have been successfully acquired or listed on the stock exchange. We are based in Stockholm, but travel across the Nordics to meet with leading ventures and investors.

Segulah Medical Acceleration specializes in investing in and nurturing transformative businesses focused on medical technologies and associated value chain solutions. These companies leverage cutting-edge research to develop real-world applications in areas like medical devices, diagnostics, and life science tools. Segulah Medical Acceleration plays a pivotal role in bridging the gap between innovative concepts and commercial validation, facilitating the global market entry of advanced medical research solutions.

Almi Invest is renowned as Sweden's leading investor in startups, operating through eight regional VC funds and one national Green Tech fund across the country. Managing a substantial equity pool of SEK 3.5 billion, Almi Invest has backed approximately 660 startups since its inception. The company's successful investments have resulted in acquisitions by major industry giants like Google, Apple, Microsoft, and Qlik, as well as through IPOs. Almi Invest operates as a venture capital firm within the Almi Group, supported by the European Regional Development Fund, Almi, Almi Invest, and regional stakeholders.

Granitor specializes in investing in cutting-edge technologies with significant commercial potential and global relevance. Primarily focused on Swedish companies, Granitor supports innovations in solar-powered water purification, sustainable food production, environmentally neutral energy solutions, zero-emissions transportation, and breakthrough medicines for previously untreatable diseases. By making early investments and maintaining a long-term commitment, Granitor aims to propel sustainable innovations forward, bridging the gap to market adoption. The firm's philosophy emphasizes active engagement and strategic leadership, playing a pivotal role in the operational and strategic development of its portfolio companies.

Navigare Ventures is an early-stage investor specializing in science-driven companies, focusing on deep tech sectors such as advanced computing, quantum technologies, synthetic biology, advanced materials, and data-driven life sciences. They are committed long-term investors, supporting companies from Seed to Series A and beyond, and emphasize forming enduring partnerships with founders. Navigare Ventures leverages their extensive industrial and scientific networks to provide capital, networks, and expertise to facilitate the transformation of science startups into successful enterprises.

HealthCap is a European venture capital firm investing globally in life sciences and has raised eight funds since 1996. HealthCap has backed and built more than 127 companies, taken more than 45 companies public, and completed numerous trade sales. The investment strategy focuses on diseases with a high unmet medical need and breakthrough therapies that have the potential to be transformative, change clinical practice, and change the lives of patients suffering from these conditions.

Trill Impact operates as a dedicated Impact House focused exclusively on impact investments. Their unique design ensures that all investments are aimed at generating positive returns while making significant impacts on people, the planet, and investors alike.